Skip to main content
Premium Trial:

Request an Annual Quote

Congenica Raises $3.3M in Series A Financing

NEW YORK (GenomeWeb) – Cambridge, UK-based Congenica today announced it has raised £2.2 million ($3.3 million) in Series A financing from Amadeus Capital Partners and Cambridge Innovation Capital.

The firm has developed Sapientia, a platform to screen whole-genome sequencing data to identify novel genetic mutations and highlight those associated with genetic disorders.

Congenica, a spinout of The Wellcome Trust Sanger Institute, will use the funds to further develop its technology, the firm said in a statement.

"We have an excellent investor base and have now achieved £5 million in funding and grants and which will help us take the technology into the clinic and accelerate our growth," Congenica CEO Tom Weaver said in a statement.

In March, Congenica received a share of £8 million in research grants awarded by Genomics England to improve genomic data analysis.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.